Registered entities
Tcr2 Therapeutics Inc.
Reg. No. 47-4152751United States
Therapeutics Inc
Reg. No. 87-0720266United States
Innovation
37 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 8,515 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 16 |
| 2022 | 16 |
| 2023 | 20 |
| 2024 | 3 |
| 2025 | 2 |
Investor mix
17 investors on record; lead investors include F2 Ventures, 6 Dimensions Capital, Curative Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 53% |
| Private equity | 2 | 12% |
| Bank & private debt | 2 | 12% |
| Other / undisclosed | 4 | 24% |